Translocations, cancer and the puzzle of specificity

Nature Genetics

Volumn 19, Issue 2, 1998, Pages 121-124

  Barr, Frederic G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELL CULTURE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME TRANSLOCATION; GENE FUSION; GENETIC LINKAGE; GENETIC RECOMBINATION; GENETIC SUSCEPTIBILITY; HUMAN; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REVIEW; SARCOMA; TUMOR SUPPRESSOR GENE;

ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; TRANSLOCATION, GENETIC;

EID: 0031838697     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/475     Document Type: Review

References (36)

1. Daley, G.Q. & Ben-Neriah, Y. Implicating the bcr/abl gene in the pathogenesis of Philadelphia Chromosome-positive human leukemia. Adv. Cancer Res. 57, 151-184 (1991).
2. Knezevich, S.R., McFadden, D.E., Tao, W., Lim, J.F. & Sorensen, P.H.B. A novel ETV6-NRTK3 gene fusion in congenital fibrosarcoma. Nature Genet 18, 184-187 (1998).
3. Rabbits, T.H. Chromosomal translocations in human cancer. Nature 372, 143-149 (1994).
4. Lowy, D.R. & Willumsen, B.M. Function and regulation of ras. Annu. Rev. Biochem. 62, 851-891 (1993).
5. Levine, A.J. p53, the cellular gatekeeper for growth and division. Cell 88, 323-331 (1997).
6. Nucifora, G. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Stood 86, 1-14 (1995).
7. Barr, F.G. Molecular genetics and pathogenesis of rhabdomyosarcoma. J. Fed. Hemat. Oncol. 19, 483-491 (1997).
8. Okuda, T., van Deursen, J., Hiebert, S.W., Grosveld, G. & Downing, J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321-330 (1996).
9. Dei Tos, A.P. & Dal Cin, P. The role of cytogenetics in the classification of soft tissue tumors. Virchows Arch. 431, 83-94 (1997).
10. May, W.A. et al. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol. Cell. Biol. 13, 7393-7398 (1993).
11. Zinszner, H., Albalat, R. & Ron, D. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev. 8, 2513-2526 (1994).
12. Daley, G.Q., McLaughlin, J., Witte, O.N. & Baltimore, D. The CML-specific P210 bcrlabl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts. Science 237, 532-535 (1987).
13. Shore, S.K., La Cava, M., Yendapalli, S. & Reddy, E.P. Structural alterations in the carboxyl-terminal domain of the BCRABL gene product activate its fibroblastic transforming potential. J. Biol. Chem. 269, 5413-5419 (1994).
14. Renshaw, M.W., McWhirter, J.R. & Wang, J.Y.J. The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation. Mol. Cell. Biol. 15, 1286-1293 (1995).
15. Sanchez-Garcia, I. & Grutz, G. Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2. Proc. Natl. Acad. Sci. USA 92, 5287-5291 (1995).
16. Grignani, F. et al. The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74, 423-431 (1993).
17. Kuroda, M. et al. Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein. Am. J. Pathol. 151, 735-744 (1997).
18. Fu, X. & Kamps, M.P. E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts. Mol. Cell. Biol. 17, 1503-1512 (1997).
19. Ferrucci, P.R. et al. Cell death induction by the acute promyelocytic leukemia-specific PML/RARα fusion protein. Proc. Natl. Acad. Sci. USA 94, 10901-10906 (1997).
20. p16INK4a. Cell 88, 593-602 (1997).
21. Evan, G.I. et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128 (1992).
22. Heisterkamp, N., Jenster, G., Kioussis, D., Pattengale, P.K. & Groffen, J. Human bcrabl gene has 3 lethal effect on embryogenesis. Transgenic Res. 1, 45-53 (1991).
23. Voncken, J.W. et al. BCRIABL P210 and P190 cause distinct leukemia in transgenic mice, Blood 86, 4603-4611 (1995).
24. David, G., Terris, B., Marchio, A., Lavau, C. & Dejean, A. The acute promyelocytic leukemia PML-RARα protein induces hepatic preneoplastic and neoplastic lesions in transgenic mice. Oncogene 14, 1547-1554 (1997).
25. Grisolano, J.L., Wesselschmidt, R.L., Pelicci, P.G. & Ley, T.J. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RARα under control of cathepsin G regulatory sequences. Blood 89, 376-387 (1997).
26. Brown, D. et al. A PMLRARα transgene initiates murine acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 94, 2551-2556 (1997).
27. Early, E. et al. Transgenic expression of PML/RARα impairs myelopoiesis. Proc. Natl. Acad. Sci. USA 93, 7900-7904 (1996).
28. Castellanos, A. et al. A BCR-ABLp190 fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. Blood 90, 2168-2174 (1997).
29. Corral, J. et al. An MII-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell 85, 853-861 (1996).
30. Yergeau, D.A. et al. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nature Genet. 15, 303-306 (1997).
31. Castilla, L.H. et al. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell 87, 687-696 (1996).
32. Haluska, F.G., Finger, L.R., Kagan, J. & Croce, C.M. Molecular genetics of chromosomal translocations in B- and T-lymphoid malignancies. in Molecular Genetics in Cancer Diagnosis (ed. Cossman, J.) 143-162 (Elsevier, New York, 1990).
33. Chissoe, S.L. et al. Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation. Genomics 27, 67-82 (1995).
34. Wang, P., Zhou, R.-H., Zou, Y., Jackson-Cook, C.K. & Povirk, L.F. Highly conservative reciprocal translocations formed by apparent joining of exchanged DNA double-strand break ends. Proc. Natl. Acad. Sci. USA 94, 12018-12023 (1997).
35. Roth, D.B. & Wilson, J.H. Nonhomologous recombination in mammalian cells: role for short sequence homologies in the joining reaction. Mol. Cell. Biol. 6, 4295-4304 (1986).
36. Aplan, P.D., Chervinsky, D.S., Stanulla, M. & Burhans, W.C. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. Blood 87, 2649-58 (1996).